Thaddeus P. Dryja, MD, currently is Vice President and Global Head of Ophthalmology Research at the Novartis Institutes for BioMedical Research (NIBR). While on the faculty of Harvard Medical School and the Massachusetts Eye and Ear Infirmary, Dr Dryja published the discovery of the retinoblastoma tumor suppressor gene in 1986 and the discovery of the first retinitis pigmentosa gene (the rhodopsin gene) in 1990. He was elected to the National Academy of Sciences in 1996.
Dryja TP, Bartley GB. Interview With Thaddeus P. Dryja, MD. Arch Ophthalmol. 2012;130(1):111–112. doi:https://doi.org/10.1001/archophthalmol.2011.382
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: